However, for glucose to be converted into 5-HMF, glucose must first be isomerized to fructose before the dehydration step 15.
The formation of 5-HMF from glucose is also important because glucose exists in great quantities as a component of cellulose. Frequently, fructose has been used to produce 5-HMF because 5-HMF is easily obtained from the furanose form through dehydration 14. Production of 5-HMF from hexoses has been studied using many solvents including water, aqueous solutions of inorganic salts or acid, and organic solvents such as dimethyl sulfoxide, N, N-dimethylformamide, and sulfolane 9, 10, 11, 12, 13. FDCA is also considered to have potential as a replacement for terephthalic acid, which is used as raw material for PET production. FDCA can be used in a range of applications, including the manufacture of green materials, pharmaceuticals, chemicals, and biopolymers 7, 8. DMF is used as a biofuel alternative for gasoline 6. 5-Hydroxymethylfurfural (5-HMF), which is derived from hexoses, is considered one of the most important building block chemicals 4, 5 because 2,5-dimethylfuran (DMF) and 2,5-furandicarboxylic acid (FDCA) can be produced from 5-HMF by hydrogenation and oxidation, respectively. These monosaccharides and their derivatives can be transformed into useful building block chemicals, which are substitutes for many chemicals derived from petroleum 3. Monosaccharides such as pentoses and hexoses are generated from cellulose and hemicelluloses in wood by hydrolysis. In recent years, wood has been utilized to produce liquid fuels and fine chemicals 1, 2. The combination of HSO 4 treatment with vacuum steam distillation is suitable for 5-HMF production because it is a one-pot process without the need for catalysts or pretreatment. The maximum yield of 5-HMF was 17.5 wt% after treatment for 45 min at 160 ☌. The HSO 4 reaction system combined with vacuum steam distillation was most effective. To avoid decomposition and to provide a means of recovering 5-HMF from HSO 4, three reaction systems based on HSO 4 were investigated: biphasic HSO 4/organic solvent system, HSO 4 with vacuum distillation, and HSO 4 with vacuum steam distillation. However, 5-HMF produced in this process tended to decompose as the treatment continued. The maximum yield of 5-HMF was about 9 wt% after 15 min of treatment at 160 ☌. Production of 5-hydroxymethylfurfural (5-HMF) from Japanese cedar ( Cryptomeria japonica) using an ionic liquid, 1-methylimidazolium hydrogen sulfate (HSO 4), was investigated. Should you continue to have any questions or concerns you may call the Litigation Trust Claim Holder Hotline at 302.888.6883 or. You should visit the claims register maintained in the bankruptcy cases.
What should I do if I believe that I am a beneficiary of the Litigation Trust?
#Synergy pharmaceuticals pro
Under the Plan, each Holder of Allowed Class 8 Interests received its Pro Rata Share of up to $1.375 million in Cash from the CRG-ESH Settlement Fund on or about July 2, 2019. The Plan provides that payment on may be made to Holders of Allowed Claims on the Distribution Date, which includes the Initial Distribution Date and Periodic Distribution Dates, as applicable. On the Effective Date, and periodically thereafter but in any event, not less than monthly), the Liquidating Debtor shall provide the Litigation Trustee with a file or database in searchable electronic format and information provided in the Litigation Trust. Such Register shall be updated from time to time as Disputed Claims become Allowed Claims. The Litigation Trust provides that record holders of trust interests shall be recorded and set forth in a register maintained by the Litigation Trustee expressly for such purpose. What does this mean for unsecured creditors or stockholders of Synergy Pharmaceuticals Inc.? Beneficiaries are defined in the Litigation Trust Agreement as “beneficiaries in interests in the Litigation Trust under the Plan, including holders of Allowed General Unsecured Claims, Allowed 510(b) Claims and Allowed Interests.” Pursuant to the Litigation Trust Agreement, certain assets were transferred to the Litigation Trust and the distributions therefrom to Beneficiaries, in accordance with the Litigation Trust Agreement, the Plan and the Court’s Confirmation Order. The Plan provided, as of May 1, 2019, the creation of a Litigation Trust and John Noble was named as the Litigation Trustee. received Bankruptcy Court approval of its wind down Chapter 11 plan (the Plan) that provides creditors with recoveries from a $195 million sale of the company’s drug treatments. On April 25, 2019, Synergy Pharmaceuticals Inc. Litigation Trust - Beneficiary Information
0 kommentar(er)
